| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Martin W Brechbiel | |
| Kwamena E Baidoo | |||
| Kwon Yong | |||
| P2860 | cites work | Astatine-211: production and availability | Q27015038 |
| Signals from within: the DNA-damage-induced NF-kappaB response | Q28291658 | ||
| Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck | Q29619277 | ||
| Clinical experience with alpha-particle emitting 211At: treatment of recurrent brain tumor patients with 211At-labeled chimeric antitenascin monoclonal antibody 81C6 | Q33705446 | ||
| An overview of targeted alpha therapy | Q34238513 | ||
| General aspects of the cellular response to low- and high-LET radiation | Q34253737 | ||
| Sequential cytarabine and alpha-particle immunotherapy with bismuth-213-lintuzumab (HuM195) for acute myeloid leukemia | Q34268110 | ||
| Towards translation of 212Pb as a clinical therapeutic; getting the lead in! | Q35028126 | ||
| (212)Pb-radioimmunotherapy induces G(2) cell-cycle arrest and delays DNA damage repair in tumor xenografts in a model for disseminated intraperitoneal disease | Q35815494 | ||
| Mechanisms of resistance to high and low linear energy transfer radiation in myeloid leukemia cells. | Q36220726 | ||
| Sensitization of tumor to ²¹²Pb radioimmunotherapy by gemcitabine involves initial abrogation of G2 arrest and blocked DNA damage repair by interference with Rad51. | Q36674828 | ||
| Recognition, signaling, and repair of DNA double-strand breaks produced by ionizing radiation in mammalian cells: the molecular choreography | Q38022419 | ||
| The centenary of discovery of radium | Q39225876 | ||
| Relative biological effectiveness of high linear energy transfer α-particles for the induction of DNA-double-strand breaks, chromosome aberrations and reproductive cell death in SW-1573 lung tumour cells | Q39421963 | ||
| Differential gene expression triggered by highly cytotoxic alpha-emitter-immunoconjugates in gastric cancer cells | Q39896063 | ||
| Effect of (211)At alpha-particle irradiation on expression of selected radiation responsive genes in human lymphocytes | Q39985891 | ||
| Local targeting of malignant gliomas by the diffusible peptidic vector 1,4,7,10-tetraazacyclododecane-1-glutaric acid-4,7,10-triacetic acid-substance p. | Q40267133 | ||
| Mechanisms of cell sensitization to alpha radioimmunotherapy by doxorubicin or paclitaxel in multiple myeloma cell lines | Q40365987 | ||
| Cell death triggered by alpha-emitting 213Bi-immunoconjugates in HSC45-M2 gastric cancer cells is different from apoptotic cell death | Q40442478 | ||
| Pharmacokinetics, dosimetry, and toxicity of the targetable atomic generator, 225Ac-HuM195, in nonhuman primates | Q44735875 | ||
| Targeted alpha-radionuclide therapy of functionally critically located gliomas with 213Bi-DOTA-[Thi8,Met(O2)11]-substance P: a pilot trial | Q48306398 | ||
| Intraperitoneal alpha-particle radioimmunotherapy of ovarian cancer patients: pharmacokinetics and dosimetry of (211)At-MX35 F(ab')2--a phase I study. | Q50605886 | ||
| A comparison of the structure of radiation oncology in the United States and Japan. | Q50753161 | ||
| Cellular kinetics, dosimetry, and radiobiology of alpha-particle radioimmunotherapy: induction of apoptosis | Q52421606 | ||
| Breaking Chemoresistance and Radioresistance with [213Bi]anti-CD45 Antibodies in Leukemia Cells | Q57384573 | ||
| Interim analysis of toxicity and response in phase 1 trial of systemic targeted alpha therapy for metastatic melanoma | Q61829445 | ||
| Radioimmunotherapy of neoplastic meningitis in rats using an alpha-particle-emitting immunoconjugate | Q72132787 | ||
| Survival of human lung epithelial cells following in vitro alpha-particle irradiation with absolute determination of the number of alpha-particle traversals of individual cells | Q73139062 | ||
| Targeted alpha particle immunotherapy for myeloid leukemia | Q74541298 | ||
| Radioimmunotherapy with alpha-emitting nuclides | Q77182049 | ||
| [Cost-benefit analysis of [224Ra] radium chloride therapy for ankylosing spondylitis (Bekhterev's disease)] | Q80625520 | ||
| In vitro experimental (211)At-anti-CD33 antibody therapy of leukaemia cells overcomes cellular resistance seen in vivo against gemtuzumab ozogamicin | Q82672455 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | adaptive radiation therapy | Q180507 |
| P304 | page(s) | 530-537 | |
| P577 | publication date | 2012-12-10 | |
| P1433 | published in | Clinical Cancer Research | Q332253 |
| P1476 | title | Molecular pathways: targeted α-particle radiation therapy | |
| P478 | volume | 19 |
| Q38712008 | A Radiolabeled Fully Human Antibody to Human Aspartyl (Asparaginyl) β-Hydroxylase Is a Promising Agent for Imaging and Therapy of Metastatic Breast Cancer |
| Q36522639 | A fully human antibody to gp41 selectively eliminates HIV-infected cells that transmigrated across a model human blood brain barrier |
| Q47557128 | Antitumor effects of radionuclide treatment using α-emitting meta-211At-astato-benzylguanidine in a PC12 pheochromocytoma model. |
| Q35220659 | Astatine-211 conjugated to an anti-CD20 monoclonal antibody eradicates disseminated B-cell lymphoma in a mouse model. |
| Q34662423 | Bone-seeking radiopharmaceuticals as targeted agents of osteosarcoma: samarium-153-EDTMP and radium-223. |
| Q37281138 | Combination of Antiretroviral Drugs and Radioimmunotherapy Specifically Kills Infected Cells from HIV-Infected Individuals |
| Q35670632 | Combining α-Radioimmunotherapy and Adoptive T Cell Therapy to Potentiate Tumor Destruction |
| Q92026257 | Comparative Radioimmunotherapy of Experimental Melanoma with Novel Humanized Antibody to Melanin Labeled with 213Bismuth and 177Lutetium |
| Q38663041 | Comparative studies on the therapeutic benefit of targeted α-particle radiation therapy for the treatment of disseminated intraperitoneal disease |
| Q92628413 | Daratumumab-225Actinium conjugate demonstrates greatly enhanced antitumor activity against experimental multiple myeloma tumors |
| Q60048015 | Development of Ac Radiopharmaceuticals: TRIUMF Perspectives and Experiences |
| Q35800092 | Dose escalation and dosimetry of first-in-human α radioimmunotherapy with 212Pb-TCMC-trastuzumab. |
| Q41385806 | Effect of densely ionizing radiation on cardiomyocyte differentiation from human-induced pluripotent stem cells |
| Q36213374 | Evaluation of cetuximab as a candidate for targeted α-particle radiation therapy of HER1-positive disseminated intraperitoneal disease |
| Q91915942 | Evaluation of novel highly specific antibodies to cancer testis antigen Centrin-1 for radioimmunoimaging and radioimmunotherapy of pancreatic cancer |
| Q91329737 | Investigation of a tellurium-packed column for isolation of astatine-211 from irradiated bismuth targets and demonstration of a semi-automated system |
| Q38259956 | Modular nanotransporters for targeted intracellular delivery of drugs: folate receptors as potential targets. |
| Q90332453 | Molecular imaging and radionuclide therapy of pheochromocytoma and paraganglioma in the era of genomic characterization of disease subgroups |
| Q35814989 | Molecular targeted α-particle therapy for oncologic applications |
| Q36447684 | Nanoconjugation of PSMA-Targeting Ligands Enhances Perinuclear Localization and Improves Efficacy of Delivered Alpha-Particle Emitters against Tumor Endothelial Analogues |
| Q37406628 | Pharmacokinetics and imaging of 212Pb-TCMC-trastuzumab after intraperitoneal administration in ovarian cancer patients |
| Q64061430 | Preclinical Evaluation of the Acute Radiotoxicity of the α-Emitting Molecular-Targeted Therapeutic Agent At-MABG for the Treatment of Malignant Pheochromocytoma in Normal Mice |
| Q48089417 | Preclinical Optimization of Antibody-based Radiopharmaceuticals for Cancer Imaging and Radionuclide Therapy - Model, Vector, and Radionuclide Selection. |
| Q36723768 | Preliminary Therapy Evaluation of (225)Ac-DOTA-c(RGDyK) Demonstrates that Cerenkov Radiation Derived from (225)Ac Daughter Decay Can Be Detected by Optical Imaging for In Vivo Tumor Visualization |
| Q87980263 | Progress in Targeted Alpha-Particle Therapy. What We Learned about Recoils Release from In Vivo Generators |
| Q34419562 | Radioimmunotherapy with α-particle-emitting radionuclides |
| Q90376283 | Radioiodination and biodistribution of newly synthesized 3-benzyl-2-([3-methoxybenzyl]thio)benzo[g]quinazolin-4-(3H)-one in tumor bearing mice |
| Q61755948 | Radionuclide Therapy of Leukemias and Multiple Myeloma |
| Q57112384 | Radium and other alpha emitters in prostate cancer |
| Q34212446 | Radium-223 dichloride bone-targeted alpha particle therapy for hormone-refractory breast cancer metastatic to bone |
| Q38194528 | Radium-223 dichloride: a review of its use in patients with castration-resistant prostate cancer with symptomatic bone metastases |
| Q35653986 | Radium-223 for the treatment of castration-resistant prostate cancer. |
| Q57179186 | Structure and properties of DOTA-chelated radiopharmaceuticals within the Ac decay pathway |
| Q52608848 | Structure-function analysis and therapeutic efficacy of antibodies to fungal melanin for melanoma radioimmunotherapy. |
| Q37686296 | Sublethal exposure to alpha radiation (223Ra dichloride) enhances various carcinomas' sensitivity to lysis by antigen-specific cytotoxic T lymphocytes through calreticulin-mediated immunogenic modulation. |
| Q90749068 | Synergistic Effect of a HER2 Targeted Thorium-227 Conjugate in Combination with Olaparib in a BRCA2 Deficient Xenograft Model |
| Q64387609 | Synergistic Effect of a Mesothelin Targeted Thorium-227 Conjugate in Combination with DNA Damage Response Inhibitors in Ovarian Cancer Xenograft Models |
| Q97420794 | Targeted Therapy With Immunoconjugates for Multiple Myeloma |
| Q26801364 | Targeted radionuclide therapies for pancreatic cancer |
| Q26752785 | Targeting Bone Metastases in Metastatic Castration-Resistant Prostate Cancer |
| Q27021990 | The development of immunoconjugates for targeted cancer therapy |
| Q28649323 | The elements of life and medicines |
| Q92712479 | The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression |
| Q41656563 | Usefulness of radium-223 in patients with bone metastases |
| Q43104006 | Using α radiation to boost cancer immunity? |
| Q54025029 | [Alpha-Radioimmunotherapy: principle and relevance in anti-tumor immunity]. |
| Q88072959 | α-Emitters for Radiotherapy: From Basic Radiochemistry to Clinical Studies-Part 1 |
Search more.